Redesign Science
Latest round
- Seed
Last raised
- Dec 2021
Total raised
- $17M
Investors
- 10
About Redesign Science
Founded in 2017 in New York, US, Redesign Science specializes in biomolecular simulations. The company was co-founded by David Rooklin and Haotian Li.The company specializes in advanced biomolecular simulations through its proprietary NUVO™ technology platform, which integrates physics-based molecular dynamics with generative AI. Their core offerings include the development of first-in-class small molecule Targeted Protein Interaction Modulators (TPIM™), which address critical challenges in therapeutic efficacy and precision medicine. These products are engineered to modulate protein interactions effectively, influencing biological pathways and disease mechanisms.The revenue model of the company is based on B2B transactions, focusing on partnerships with pharmaceutical firms and research organizations. Clients engage through structured collaborations, which may involve multi-year agreements for access to the NUVO™ platform and its associated technologies. The company aims to enhance its offerings, potentially leading to the introduction of new products, while also targeting expansion into additional global markets to further support its growth strategy.
Who invested in Redesign Science
10 investors across 3 rounds
See all investors in Redesign Science
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Redesign Science
Who invested in Redesign Science?
Redesign Science has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Redesign Science raised?
Redesign Science has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Redesign Science last raise money?
Redesign Science's most recent round on record is a Seed, in Dec 2021.
What does Redesign Science do?
Founded in 2017 in New York, US, Redesign Science specializes in biomolecular simulations.
Where is Redesign Science headquartered?
Redesign Science is headquartered in New York, US.
Which VCs invest in companies like Redesign Science?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Redesign Science's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Redesign Science? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.